The Pennant Group (PNTG) Competitors $29.37 -0.06 (-0.22%) As of 09:54 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PNTG vs. BTSG, SHC, PRVA, SGRY, CON, VCYT, LFST, ARDT, ADUS, and PGNYShould you be buying The Pennant Group stock or one of its competitors? The main competitors of The Pennant Group include BrightSpring Health Services (BTSG), Sotera Health (SHC), Privia Health Group (PRVA), Surgery Partners (SGRY), Concentra Group Holdings Parent (CON), Veracyte (VCYT), LifeStance Health Group (LFST), Ardent Health Partners (ARDT), Addus HomeCare (ADUS), and Progyny (PGNY). These companies are all part of the "healthcare" industry. The Pennant Group vs. BrightSpring Health Services Sotera Health Privia Health Group Surgery Partners Concentra Group Holdings Parent Veracyte LifeStance Health Group Ardent Health Partners Addus HomeCare Progyny BrightSpring Health Services (NASDAQ:BTSG) and The Pennant Group (NASDAQ:PNTG) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, profitability, valuation, community ranking, risk, institutional ownership, earnings, analyst recommendations and media sentiment. Which has higher earnings and valuation, BTSG or PNTG? The Pennant Group has lower revenue, but higher earnings than BrightSpring Health Services. The Pennant Group is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBrightSpring Health Services$11.86B0.35-$154.60M$0.2885.07The Pennant Group$748.17M1.36$13.38M$0.7638.72 Do analysts prefer BTSG or PNTG? BrightSpring Health Services currently has a consensus target price of $23.56, suggesting a potential downside of 1.11%. The Pennant Group has a consensus target price of $35.60, suggesting a potential upside of 20.97%. Given The Pennant Group's higher possible upside, analysts clearly believe The Pennant Group is more favorable than BrightSpring Health Services.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BrightSpring Health Services 0 Sell rating(s) 1 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.90The Pennant Group 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.60 Does the media prefer BTSG or PNTG? In the previous week, BrightSpring Health Services had 1 more articles in the media than The Pennant Group. MarketBeat recorded 12 mentions for BrightSpring Health Services and 11 mentions for The Pennant Group. BrightSpring Health Services' average media sentiment score of 1.32 beat The Pennant Group's score of 1.20 indicating that BrightSpring Health Services is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BrightSpring Health Services 10 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive The Pennant Group 8 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility and risk, BTSG or PNTG? BrightSpring Health Services has a beta of 2.06, indicating that its share price is 106% more volatile than the S&P 500. Comparatively, The Pennant Group has a beta of 1.56, indicating that its share price is 56% more volatile than the S&P 500. Does the MarketBeat Community believe in BTSG or PNTG? The Pennant Group received 14 more outperform votes than BrightSpring Health Services when rated by MarketBeat users. However, 87.50% of users gave BrightSpring Health Services an outperform vote while only 46.15% of users gave The Pennant Group an outperform vote. CompanyUnderperformOutperformBrightSpring Health ServicesOutperform Votes2887.50% Underperform Votes412.50%The Pennant GroupOutperform Votes4246.15% Underperform Votes4953.85% Is BTSG or PNTG more profitable? The Pennant Group has a net margin of 3.24% compared to BrightSpring Health Services' net margin of -0.38%. The Pennant Group's return on equity of 13.47% beat BrightSpring Health Services' return on equity.Company Net Margins Return on Equity Return on Assets BrightSpring Health Services-0.38% 4.16% 0.99% The Pennant Group 3.24%13.47%3.81% Do insiders & institutionals have more ownership in BTSG or PNTG? 85.9% of The Pennant Group shares are owned by institutional investors. 5.8% of The Pennant Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. SummaryThe Pennant Group beats BrightSpring Health Services on 11 of the 18 factors compared between the two stocks. Get The Pennant Group News Delivered to You Automatically Sign up to receive the latest news and ratings for PNTG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PNTG vs. The Competition Export to ExcelMetricThe Pennant GroupHealth services IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.01B$851.11M$5.43B$8.48BDividend YieldN/A2.30%5.22%4.11%P/E Ratio43.2854.4226.8320.05Price / Sales1.3610.17394.87116.44Price / Cash32.9226.1438.2534.62Price / Book6.064.036.874.61Net Income$13.38M-$5.50M$3.22B$248.19M7 Day Performance0.41%6.51%6.82%2.97%1 Month Performance20.12%57.81%13.72%16.58%1 Year Performance24.28%21.12%18.31%8.16% The Pennant Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PNTGThe Pennant Group2.8468 of 5 stars$29.37-0.2%$35.60+21.2%+27.3%$1.01B$748.17M43.195,340Positive NewsGap UpBTSGBrightSpring Health Services1.6611 of 5 stars$22.35-2.1%$22.89+2.4%+108.0%$3.89B$11.86B-85.9635,000Positive NewsGap UpHigh Trading VolumeSHCSotera Health2.1906 of 5 stars$13.50+2.8%$15.80+17.0%+15.6%$3.83B$1.11B54.003,000Gap UpPRVAPrivia Health Group3.6786 of 5 stars$25.06+0.2%$27.38+9.3%+52.4%$3.04B$1.80B250.63810SGRYSurgery Partners2.818 of 5 stars$23.26+5.0%$34.75+49.4%-8.9%$2.98B$3.11B-48.4612,200CONConcentra Group Holdings ParentN/A$21.66+1.2%$28.50+31.6%N/A$2.76B$1.90B16.1611,000Gap UpVCYTVeracyte4.033 of 5 stars$30.76+3.5%$40.90+33.0%+29.2%$2.41B$445.76M-205.07790News CoverageGap UpLFSTLifeStance Health Group2.5843 of 5 stars$5.85+2.1%$8.30+41.9%-22.4%$2.27B$1.28B-22.506,640ARDTArdent Health Partners3.2474 of 5 stars$14.85+2.3%$20.75+39.7%N/A$2.12B$6.02B9.1124,200Analyst ForecastADUSAddus HomeCare4.8207 of 5 stars$110.55-0.3%$142.57+29.0%+1.7%$2.04B$1.21B25.3033,200PGNYProgyny0.8951 of 5 stars$22.00+3.8%$23.45+6.6%-21.9%$1.88B$1.17B37.93310Positive News Related Companies and Tools Related Companies BTSG Competitors SHC Competitors PRVA Competitors SGRY Competitors CON Competitors VCYT Competitors LFST Competitors ARDT Competitors ADUS Competitors PGNY Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PNTG) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Pennant Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share The Pennant Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.